InvestorsHub Logo
Followers 9
Posts 454
Boards Moderated 0
Alias Born 10/14/2016

Re: None

Friday, 05/12/2017 11:37:22 AM

Friday, May 12, 2017 11:37:22 AM

Post# of 41375
as for comparison with TBRA scenario to AMDA:

1. TBRA had $1 million revenue but was bought out @ $1.7 BILLIONS plus they had a FAILED drug before the BO took place.

2. you see they have an internal audit of 10Q/A before the 8K of BO news too...very similar to what is happening to amda scenario

3. The buyer saw the value of TBRA failed drug...amda' Si3n4 2nd gen is priceless worldwide patents. In addition, Weigao deals alone is in the range of $300 mils..I don't really know how much amda valuation though.

reference link of tbra #:

date announced BO:
http://www.investors.com/news/tobira-shares-multiply-on-1-7-billion-buyout-from-allergan/

8k announced BO:
https://seekingalpha.com/filing/3229715

10Q shows only $1 mil revenue:
https://seekingalpha.com/filing/3179433

all SEC filings before their BO news:
https://seekingalpha.com/symbol/TBRA/key-data/filings

In conclusion, only god knows the real valuation of amda!



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News